GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (GREY:ADDXF) » Definitions » Cyclically Adjusted PB Ratio

Addex Therapeutics (Addex Therapeutics) Cyclically Adjusted PB Ratio : (As of Jun. 10, 2024)


View and export this data going back to . Start your Free Trial

What is Addex Therapeutics Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Addex Therapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Addex Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Cyclically Adjusted PB Ratio Chart

Addex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.03

Addex Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.04 0.03 0.03 0.06

Competitive Comparison of Addex Therapeutics's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Addex Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Addex Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Addex Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Addex Therapeutics's Cyclically Adjusted PB Ratio falls into.



Addex Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Addex Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Addex Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.029/107.3549*107.3549
=-0.029

Current CPI (Mar. 2024) = 107.3549.

Addex Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
200912 12.828 101.610 13.553
201006 9.146 102.102 9.617
201012 10.496 102.138 11.032
201106 7.696 102.678 8.047
201112 4.445 101.408 4.706
201206 2.593 101.596 2.740
201212 1.800 100.968 1.914
201306 0.358 101.466 0.379
201312 0.344 101.036 0.366
201406 0.232 101.517 0.245
201412 0.241 100.704 0.257
201506 0.267 100.464 0.285
201512 0.152 99.386 0.164
201606 0.107 100.088 0.115
201612 0.019 99.380 0.021
201706 0.185 100.285 0.198
201712 0.101 100.213 0.108
201806 1.619 101.435 1.713
201812 1.498 100.906 1.594
201903 0.000 101.571 0.000
201906 1.233 102.044 1.297
201909 0.000 101.396 0.000
201912 0.976 101.063 1.037
202003 0.851 101.048 0.904
202006 0.741 100.743 0.790
202009 0.649 100.585 0.693
202012 0.606 100.241 0.649
202103 0.654 100.800 0.697
202106 0.530 101.352 0.561
202109 0.423 101.533 0.447
202112 0.485 101.776 0.512
202203 0.368 103.205 0.383
202206 0.187 104.783 0.192
202209 0.154 104.835 0.158
202212 0.099 104.666 0.102
202303 0.083 106.245 0.084
202306 0.128 106.576 0.129
202309 0.082 106.570 0.083
202312 0.025 106.461 0.025
202403 -0.029 107.355 -0.029

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Addex Therapeutics  (GREY:ADDXF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Addex Therapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Addex Therapeutics (Addex Therapeutics) Business Description

Traded in Other Exchanges
Address
Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202
Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (Addex Therapeutics) Headlines

From GuruFocus

Enamine Extend Collaboration With Prominent Swiss Biotech

By Business Wire Business Wire 02-24-2021